Chemical Structure : Linifanib
CAS No.: 796967-16-3
货号: PC-45859Not For Human Use, Lab Use Only.
Linifanib (ABT-869) is a potent multi-RTKs inhibitor of members of VEGFR and PDGFR families with IC50 of 4/3/3/14/4/66/190/170 nM for KDR/FLT1/CSF1R/KIT/FLT3/PDGFRβ/FLT4/Tie2, respectively.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | ¥580 | In stock | |
| 25 mg | ¥880 | In stock | |
| 100 mg | ¥1580 | In stock | |
| 250 mg | ¥2480 | In stock | |
| 1 g | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Linifanib (ABT-869) is a potent multi-RTKs inhibitor of members of VEGFR and PDGFR families with IC50 of 4/3/3/14/4/66/190/170 nM for KDR/FLT1/CSF1R/KIT/FLT3/PDGFRβ/FLT4/Tie2, respectively.
Linifanib (ABT-869) shows much less active (IC50>10 uM) against other nonrelated tyrosine kinases, such as steroid receptor coactivator and EGFR.
Linifanib (ABT-869) inhibits RTK phosphorylation (IC50=2, 4, and 7 nM for PDGFRβ, KDR, and CSF-1R, respectively) and VEGF-stimulated proliferation (IC50=0.2 nM for human endothelial cells).
Linifanib (ABT-869) exhibits efficacy in human fibrosarcoma and breast, colon, and small cell lung carcinoma xenograft models (ED50=1.5-5 mg/kg, twice daily).
Linifanib (ABT-869) also is a small molecule inhibitor of necroptosis by targeting RIPK1 kinase
| 分子量 | 375.3989 | |
| 分子式 | C21H18FN5O | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
Urea, N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl)- |
|
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright